As reported on MedicalXpress, a new study published in Molecular Psychiatry suggests that a specific circular RNA found in blood, known as CDR1as, may help
As reported on BioPharmaDive, Aardvark Therapeutics has halted dosing and enrollment in its late‑stage HERO trial for ARD‑101, a first‑in‑class treatment candidate for Prader–Willi syndrome
Editor’s Note: Patient Worthy is pleased to bring you this article, originally shared with us by our friend Julie Lanford, The Cancer Dietitian. To see
The landscape of advanced breast cancer treatment is shifting. Genentech’s filing acceptance of giredestrant, an experimental oral medication, represents a pivotal moment for thousands of
As reported in Business Wire, Vico Therapeutics has initiated patient dosing in an expanded cohort of its Phase 1/2a clinical study evaluating VO659, an antisense
Editor’s Note: This article was shared with us by our friends at Heal Canada. To see the article in its original format, please click here.
AbbVie has announced a landmark regulatory milestone with the US FDA’s approval of a supplemental new drug application (sNDA) for the combination of Venclexta (venetoclax)
As published in Sleep Review Magazine, Axsome Therapeutics has officially begun dosing patients in its Phase 3 CLARITY trial, a study designed to evaluate solriamfetol
Fibrosis, the accumulation of scar tissue in organs, disrupts normal organ function and leads to progressive impairment. Currently, there is no cure, and existing treatments
The relationship between people with type 1 diabetes and their medication has always been complicated. For decades, managing the condition has required constant vigilance including
As reported on PharmaBiz, Harness Therapeutics has selected HRN001 as its lead therapeutic candidate for Huntington’s disease (HD), marking a major milestone for the company
Click here to see Part 1 of of this 3 part pain series. If you suffer with chronic pain, you not only live with the unrelenting
Patients using Zepbound for weight management now have a simpler option for administering their medication. As reported by PharmaLive.com, Eli Lilly received FDA clearance for
On this episode of Wait, How Do You Spell That?, host Bree Clare sits down with Dr. Charles Link, a pioneering oncologist whose career has
At 44 years old, I was ready to hit the reset button. In March of 2025, my partner and I stepped away from our careers.
Ovarian cancer is a serious gynecological cancer with no reliable screening test, resulting in limited treatment options and a low number of survivors. Each year
Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for Priority Review the Biologics License Application (BLA) for garetosmab, marking a significant
AstraZeneca and Daiichi Sankyo’s antibody‑drug conjugate Datroway (datopotamab deruxtecan) has been granted Priority Review by the U.S. Food and Drug Administration (FDA) for use as
This week at Patient Worthy, we’re celebrating the strength and resilience of those living with Tardive Dyskinesia. Throughout the week, we’ll highlight empowering stories, share helpful insights, and create a supportive space where patients and caregivers can feel seen, heard, and connected.
Whether you’re seeking information, community, or encouragement, visit patientworthy.com for uplifting resources and ongoing updates. Your voice matters!
If you have a story to share, click the link below.
bit.ly/4dV7gru
#TardiveDyskinesia #TD #MovementDisorders #NeurologicalHealth #PatientWorthy #ShareYourStory
Alagille Syndrome Alliance @lLverFoundation💛 A Story of Strength, Resilience, and Hope 💛
We’re honored to share a powerful video from the Liver Foundation featuring Jasper and his dad, Peter, as they open up about their journey with Alagille Syndrome.
From Jasper’s diagnosis in early childhood to growing up with chronic liver disease and facing the possibility of a liver transplant, their story offers an honest and heartfelt look at living with ALGS.
Stories like Jasper’s remind us why community, awareness, and advocacy matter so deeply. 💛
We invite you to watch and share:
🎥 zurl.co/MSjmj
Thank you to the Liver Foundation for helping shine a light on the ALGS journey.
#AlagilleSyndrome #ALGS #RareDisease #ChronicIllness #TransplantAwareness #PatientStories
National PKU Alliance #pku #metabolicdiseaseEmail [email protected] to register for this week's community call!
© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
